Search Results - jonathan+stamler

1 Results

Sort By:

Reactive Oxygen Generating Enzyme Inhibitor with Nitric Oxide Bioactivity and Uses Thereof

Technical Details: In the US, CHF is the number one cause of hospitalization in people over age 65, and it affected approximately 5 million people in 2004. This translates into a potential cost of $29 billion for the healthcare system. In the US over half a million new cases are diagnosed with, and over 50,000 individuals die from CHF each year. Current...

Published: 3/13/2025 | Inventor(s): Jonathan Stamler, Eric Toone, Joshua Hare

Keywords(s): Agonists/Promoters, Cardiovascular Diseases, Congestive Heart Failure, Congestive Heart Failure (CHF), Disease Indication, Novel, Predicted Novelty, Single, Small Molecules, Targeted Therapy, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Cardiovascular > Congestive Heart Failure, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities > Targets, Clinical and Disease Specializations > Cardiovascular, Technology Classifications > Therapeutic Modalities